Precision Optics (NASDAQ:POCI) Announces Quarterly Earnings Results

Precision Optics (NASDAQ:POCI) posted its earnings results on Thursday. The company reported ($0.15) earnings per share for the quarter, Zacks reports. Precision Optics had a negative net margin of 20.01% and a negative return on equity of 35.51%.

Precision Optics Price Performance

NASDAQ POCI traded up $0.04 during trading hours on Thursday, reaching $4.99. The company’s stock had a trading volume of 2,206 shares, compared to its average volume of 8,800. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.76 and a current ratio of 1.41. The company’s 50-day moving average is $5.02 and its two-hundred day moving average is $5.06. Precision Optics has a fifty-two week low of $3.47 and a fifty-two week high of $6.90. The stock has a market cap of $31.69 million, a PE ratio of -8.05 and a beta of 0.28.

Insiders Place Their Bets

In other news, Director Peter V. Anania sold 14,400 shares of Precision Optics stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $5.00, for a total transaction of $72,000.00. Following the completion of the sale, the director now directly owns 196,198 shares in the company, valued at $980,990. The trade was a 6.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 16.30% of the stock is currently owned by company insiders.

Precision Optics Company Profile

Precision Optics Corporation, Inc designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.